DFDA

Metoprolol

Treatment for Rheumatic Heart Disease

Typical Dosage: 25-200mg daily

Effectiveness
85%
Safety Score
65%
Clinical Trials
1
Participants
80K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
65
DangerousModerateSafe
Treatment Details
Dosage Range
25-200mg daily
Time to Effect
days to weeks
Treatment Duration
lifetime
Evidence Quality
HIGH
Number Needed to Treat (NNT)
18(Treat 18 patients to see 1 additional successful outcome)
Number Needed to Harm (NNH)
300(Treat 300 patients to see 1 additional serious adverse event)
Confidence Score
90%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$20
Monitoring:$300
Side Effect Mgmt:$50
Total Annual:$370
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
ICER
$15,000/QALY
QALYs Gained
1.5
Outcome-Based Costs
Cost per Responder
$493
Metoprolol Outcomes

for Rheumatic Heart Disease

Efficacy Outcomes
Overall Effectiveness
+85%
Response Rate
+75%
Common Side Effects
Fatigue
+15%
Bradycardia
+10%
Hypotension
+10%
Dizziness
+8%

Sources:

researchgate.net
acc.org
nih.gov

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov